Drug Profile
MAXY G34
Alternative Names: Maxy-G34; Maxy-GCSF; PEG-MAXY-G34; pegylated-MAXY-G34Latest Information Update: 07 Jun 2013
Price :
$50
*
At a glance
- Originator Maxygen
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Recombinant proteins
- Mechanism of Action Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Neutropenia
Most Recent Events
- 07 Jun 2013 Discontinued - Phase-I for Neutropenia in USA (SC)
- 07 Jun 2013 Discontinued - Phase-II for Neutropenia in Poland (SC)
- 07 Jun 2013 Discontinued - Phase-II for Neutropenia in Romania (SC)